Results 201 to 210 of about 8,545 (211)

Liposomal Nanovaccine Containing α-Galactosylceramide and Ganglioside GM3 Stimulates Robust CD8+ T Cell Responses via CD169+ Macrophages and cDC1

Vaccines, 2021
Yvette van Kooyk, Hans van der Vliet, Joke M M Den Haan   +2 more
exaly  

Immunoactive nanoparticle boosted cDC1 for in situ cancer immunotherapy

PURPOSE: Cancer immunotherapy, which aims to stimulate the immune system to induce antigen specific immune responses against cancers, has emerged as a promising approach for cancer intervention. However, eliciting an effective antitumor immune response is hindered by the scarcity of appropriate antigen-presenting cells (APCs) and their impaired ...
openaire   +1 more source

Mechanisms of Cross-Presentation by cDC1s

2020
openaire   +1 more source

CDC1

2008
openaire   +1 more source

Characterization and expression of DEC205 in the cDC1 and cDC2 subsets of porcine dendritic cells from spleen, tonsil, and submaxillary and mesenteric lymph nodes

Molecular Immunology, 2018
Olivia Valenzuela, Lucinda Puebla-Clark   +1 more
exaly  

Differential chemokine receptor expression and usage by pre‐cDC1 and pre‐cDC2

Immunology and Cell Biology, 2018
Quintin Lee, Andreas Schlitzer, Md Gorrell   +2 more
exaly  

NCoR1 fine‐tunes type‐I IFN response in cDC1 dendritic cells by directly regulating Myd88‐IRF7 axis under TLR9

European Journal of Immunology, 2020
Sunil Kumar Raghav, Dominique Garcin, Viplov Kumar Biswas   +2 more
exaly  

Response of the cDC1 and cDC2 subtypes of tracheal dendritic cells to porcine reproductive and respiratory syndrome virus

Veterinary Microbiology, 2018
Olivia Valenzuela
exaly  

OXPHOS fuels cDC1s

Nature Immunology
openaire   +1 more source

cDC1s license CD8+ T cell-mediated neurodegeneration

Nature Reviews Immunology
Jonathan K. Monteiro, Véronique E. Miron   +1 more
openaire   +1 more source